Bi-specific T-cell engager

Bi-specific T-cell engager is a class of artificial bispecific monoclonal antibodies that are used to treat cancer. They direct a host’s immune system, more specifically the T cells’ cytotoxic activity, against cancer cells.
They are fusion proteins that are created by joining parts of two different genes. They are transcribed and translated as a single unit, producing a single polypeptide.

Showing the single result

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price
CD19
,
CD3
Bi-specific T-cell engager
Blincyto®
0,0125 mg/mL
0,002 mg
2-8°C/-80°C
12/2024
945,00 
view product
Max: 10
Min: 1
Step: 1

Not looking for Bi-specific T-cell engager?

Search our therapeutic molecules product database

Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.

we are recruiting